- Home
- PDD vs PFE Comparison
PDD vs PFE Comparison
Compare PDD & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDD
- PFE
- Stock Information
- Founded
- PDD 2015
- PFE 1849
- Country
- PDD Ireland
- PFE United States
- Employees
- PDD N/A
- PFE N/A
- Industry
- PDD Business Services
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- PDD Consumer Discretionary
- PFE Health Care
- Exchange
- PDD Nasdaq
- PFE Nasdaq
- Market Cap
- PDD 131.9B
- PFE 166.8B
- IPO Year
- PDD 2018
- PFE N/A
- Fundamental
- Price
- PDD $123.63
- PFE $29.28
- Analyst Decision
- PDD Strong Buy
- PFE Buy
- Analyst Count
- PDD 10
- PFE 12
- Target Price
- PDD $182.40
- PFE $33.91
- AVG Volume (30 Days)
- PDD 20.7M
- PFE 30.6M
- Earning Date
- PDD 11-26-2024
- PFE 10-29-2024
- Dividend Yield
- PDD N/A
- PFE 5.74%
- EPS Growth
- PDD 137.72
- PFE N/A
- EPS
- PDD 9.26
- PFE N/A
- Revenue
- PDD $47,006,701,131.00
- PFE $55,166,000,000.00
- Revenue This Year
- PDD $65.02
- PFE $5.66
- Revenue Next Year
- PDD $28.09
- PFE $3.34
- P/E Ratio
- PDD $13.76
- PFE N/A
- Revenue Growth
- PDD 106.72
- PFE N/A
- 52 Week Low
- PDD $88.01
- PFE $25.20
- 52 Week High
- PDD $164.69
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- PDD 44.74
- PFE 50.84
- Support Level
- PDD $138.10
- PFE $28.85
- Resistance Level
- PDD $145.37
- PFE $29.82
- Average True Range (ATR)
- PDD 6.22
- PFE 0.53
- MACD
- PDD -2.51
- PFE 0.04
- Stochastic Oscillator
- PDD 3.93
- PFE 47.26
About PDD PDD Holdings Inc.
PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. PDD aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from the increased productivity and new opportunities. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.